298 Hits
Brindha
Feb 4, 2022, 1:03 PM
A decade after two blood cancer patients received a novel type of immunotherapy involving immune cells called T-cells that had been genetically engineered, the cells are still in the people’s bodies and their cancer is still in remission. A T-cell (orange) is shown attacking a cancer cell (blue) in this illustration.
Read More
262 Hits
Brindha
Feb 4, 2022, 12:38 PM
The "rolling stop" feature introduced by Tesla in October meant that cars rolled past stop signs instead of stopping, as...
Read More
266 Hits
Brindha
Feb 3, 2022, 6:25 PM
Patients hospitalised with COVID-19 are at risk for thrombotic events after discharge; the role of extended thromboprophylaxis in this population...
Read More
